1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators

This specification generally relates to 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds (including salts thereof). The 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds of the invention have SGRM activity. This specification also relates to pharmaceutical compositions and kits comprising such a compou...

Full description

Saved in:
Bibliographic Details
Main Authors Ripa Lena Elisabeth, Edman Karl, Lepistö Matti Juhani, Lawitz Karolina, Hemmerling Martin, Llinas Antonio
Format Patent
LanguageEnglish
Published 23.03.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This specification generally relates to 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds (including salts thereof). The 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds of the invention have SGRM activity. This specification also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including treatment methods and medicament preparations for the treatment of conditions comprising rheumatoid arthritis and/or asthma), and processes for making such a compound.
Bibliography:Application Number: NZ20150730250